Tapewire

OTC · USD

GTHP

GUIDED THERAPEUTICS INC

Export transactions ↓
Tapewire entity
7610
SEC CIK
0000924515
Parsed reports
49

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2022 Filed Jun 2, 2023 22:25 UTC
JAMES MICHAEL CDirector · 10% owner
PurchaseWarrants · Derivative 100,000 Not disclosed Strike: $0.50 Not disclosed
Disclosure

SEC source: 0001477932-23-004225 · form4.xml · derivative · entry 2

JAMES MICHAEL C · CIK 0001365831 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-09-01

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. James pursuant to which the Company issued 100,000 shares of its common stock, four year warrants to purchase an aggregate of 100,000 shares of Common Stock at $0.50 per share and 100,000 shares of Common Stock at $0.65 per share for an aggregate purchase price of $50,000.

Read SEC document
September 01, 2022 Filed Jun 26, 2023 16:19 UTC
Imhoff John EDirector · 10% owner
PurchaseWarrants · Derivative 500,000 Not disclosed Strike: $0.65 Not disclosed
Disclosure

SEC source: 0001477932-23-004757 · form4.xml · derivative · entry 3

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2026-09-01

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Imhoff pursuant to which the Company issued 500,000 shares of its common stock, four-year warrants to purchase an aggregate of 500,000 shares of common stock for $0.50 per share and four-year warrants to purchase 500,000 shares of common stock for $0.65 per share for an aggregate purchase price of $250,000.

Read SEC document
September 01, 2022 Filed Jun 26, 2023 16:19 UTC
Imhoff John EDirector · 10% owner
PurchaseWarrants · Derivative 500,000 Not disclosed Strike: $0.50 Not disclosed
Disclosure

SEC source: 0001477932-23-004757 · form4.xml · derivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2026-09-01

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Imhoff pursuant to which the Company issued 500,000 shares of its common stock, four-year warrants to purchase an aggregate of 500,000 shares of common stock for $0.50 per share and four-year warrants to purchase 500,000 shares of common stock for $0.65 per share for an aggregate purchase price of $250,000.

Read SEC document
September 01, 2022 Filed Jun 27, 2023 15:59 UTC
Blumberg Richard P.Director · 10% owner
PurchaseWarrants · Derivative 1,000,000 Not disclosed Strike: $0.65 Not disclosed
Disclosure

SEC source: 0001477932-23-004804 · form4.xml · derivative · entry 3

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common shares · 1,000,000 shares

Expires 2026-09-01

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Blumberg pursuant to which the Company issued 1,000,000 shares of its common stock, four-year warrants to purchase an aggregate of 1,000,000 shares of common stock for $0.50 per share and four-year warrants to purchase 1,000,000 shares of common stock for $0.65 per share for an aggregate purchase price of $500,000.

Read SEC document
September 01, 2022 Filed Jun 27, 2023 15:59 UTC
Blumberg Richard P.Director · 10% owner
PurchaseWarrants · Derivative 1,000,000 Not disclosed Strike: $0.50 Not disclosed
Disclosure

SEC source: 0001477932-23-004804 · form4.xml · derivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common shares · 1,000,000 shares

Expires 2026-09-01

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Blumberg pursuant to which the Company issued 1,000,000 shares of its common stock, four-year warrants to purchase an aggregate of 1,000,000 shares of common stock for $0.50 per share and four-year warrants to purchase 1,000,000 shares of common stock for $0.65 per share for an aggregate purchase price of $500,000.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.